(Total Views: 385)
Posted On: 06/27/2022 3:18:02 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
We need for someone like Pfizer’s ervogastat/clesacostat as a potential treatment for NASH to feel threatened and therefore they come in and buy Leronlimab. Maybe the EASL gave us that platform.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)